IRYCIS Outstanding publication

• Tuesday, 8 September 2026

  Hernández M, Pérez B, Nieto M, García M, Michelena M, Martínez L, Baquero F, Ruiz P, Cantón R. Addressing therapeutic options for KPC-3-producing ST307- Klebsiella pneumoniae: insights from in vitro evolution and mutant prevention strategies

  Antimicrob Agents Chemother. 2026

  10.1128/aac.00488-26

• Tuesday, 25 August 2026

  Maturi FE, Ximendes E, Benayas A, Ortgies DH, Martín E, Haro P, Jaque D. Sensing with (One or Many) Upconverting Nanoparticles

  Acc Chem Res. 2026

  10.1021/acs.accounts.5c00896

• Wednesday, 19 August 2026

  García-Regal C, Quiñones-Silva J, Martinez-Lorca A, Brox-Torrecilla N, Campos Mena S, Alonso-Gordoa T, Gómez-Ramírez J, Valderrabano P. Determinants of physicians' risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer

  Endocrine. 2026

  10.1007/s12020-026-04717-1

• Wednesday, 29 July 2026

  Rodriguez de Santiago E, Teruel Sanchez C, Albeniz E, Estremera F, Arrubla A, Castel de Lucas I, Arribas J, Marin JC, Diez P, Nunez H, Herreros de Tejada A, El Haira I, Riu F, Naves J, Uchima H, Marin I, Duque JM, Perez D, De Maria P, Perez I, Garcia C, Lorenzo V, Nogales O, Muriel A, Albillos A. Multicenter, double-blind, sham endoscopy-controlled, randomized trial evaluating the efficacy of antireflux mucosal ablation for the treatment of gastroesophageal reflux disease

  Endoscopy. 2025

  10.1055/a-2780-0706